# MELOXICAM
> **ANDA220010** · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2026-10-15
## Drug
- **FDA Application Number:** ANDA220010
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MELOXICAM
- **Generic name:** Meloxicam
- **Active ingredients:** MELOXICAM
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVITIUM PHARMA
- **First approval:** 2026-10-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220010)
---
*MORVS · CC0 1.0*